CWM
CELL

Compass Wealth Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Compass Wealth Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,242
Closed -$2.24K – 418
2023
Q3 		$2.24K Hold
2,242
– – ﹤0.01% 379
2023
Q2 		$1.1K Hold
2,242
– – ﹤0.01% 395
2023
Q1 		$2.6K Buy
+2,242
New +$4.1K ﹤0.01% 395

Compass Wealth Management's CELL Position: Q4 2023 in Review

Compass Wealth Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 2,242 shares — an estimated $2.24K sold.

Compass Wealth Management first reported a position in CELL in Q1 2023 and held it in 3 quarters. The position peaked at $2.6K in Q1 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Compass Wealth Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Compass Wealth Management sold 2,242 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $2.24K.
  • Compass Wealth Management first reported a position in PhenomeX Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Compass Wealth Management's PhenomeX Inc. Common Stock position peaked at $2.6K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Compass Wealth Management's 13F filing for Q4 2023, filed 4 Jan 2024.